Nigeria is set to launch Africa's first trial programme to use cheap, imported, generic Aids drugs to combat the disease sweeping the continent. Aiming to tackle the effects of an epidemic now affecting almost 3,5 million Nigerians, and more than 28 million Africans, the programme will start in 18 federal health centres on a limited number of patients.